Moderna Inc (MRNA) — Cash Flow Reinvestment Rate
Moderna Inc (MRNA) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting $48.00 Million (capex $39.00 Million plus investments $-9.00 Million) from operating cash flow of $951.00 Million. Explore Moderna Inc capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Moderna Inc Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for Moderna Inc across 4 annual periods. Also explore MRNA total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Moderna Inc (2016–2022)
Year-by-year capital reinvestment analysis for Moderna Inc. For live market cap and broader valuation context, see Moderna Inc (MRNA) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.12x | $5.58 Billion | $4.98 Billion | $400.00 Million | ▲ +78.9% |
| 2021 | 0.63x | $8.52 Billion | $13.62 Billion | $284.00 Million | ▼ -24.1% |
| 2020 | 0.82x | $1.67 Billion | $2.03 Billion | $67.45 Million | ▼ -91.9% |
| 2016 | 10.22x | $681.75 Million | $66.73 Million | $33.14 Million | — |